# Feasibility and Safety of Augmented Reality (AR) in Liver Tumor Surgery

> **NCT07630610** · NA · NOT_YET_RECRUITING · sponsor: **Navari Surgical AB** · enrollment: 6 (estimated)

## Conditions studied

- Liver Neoplasms

## Interventions

- **PROCEDURE:** Augmented reality guided liver tumor surgery
- **DEVICE:** Augmented reality (AR) guided liver tumor surgery

## Key facts

- **NCT ID:** NCT07630610
- **Lead sponsor:** Navari Surgical AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-02-01
- **Final completion:** 2027-02-01
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07630610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07630610, "Feasibility and Safety of Augmented Reality (AR) in Liver Tumor Surgery". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07630610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*